The three most common molecular subtypes of breast cancers based on the coding genome are HR+ malignancies (estrogen receptor-positive (ER+) and progesterone receptor positive (PR+) breast cancers) [9], HER2+, and triple-negative breast cancer (TNBC) malignancies. This evidence concerns the gene ERBB2 and breast cancer.